News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

LABS Inc. Announces Alliance with Ambry Genetics to Expand Testing Solutions for the Reproductive Health Industry


3/15/2011 7:34:38 AM

CENTENNIAL, Colo. and ALISO VIEJO, Calif., March 15, 2011 /PRNewswire/ -- LABS, Inc., the recognized leader in microbiology, infectious disease screening, cell/molecular biology and immunological testing for the transplant and biomedical sciences communities, today announced an agreement with Ambry Genetics, a global leader in molecular diagnostics and genomic services to the healthcare and life sciences industries, that will allow the organizations to provide superior testing services to a broader base of clients in the reproductive health industry.

This partnership will make Ambry Genetics the preferred provider of genetic carrier screening for LABS, Inc., giving LABS' testing clients access to AmbryScreen, a genetic screening test used to identify carriers of some of the most severe and common childhood diseases affecting pan-ethnic populations.

"This partnership brings two premier laboratories together to offer new donor and patient screening options combined with an elite level of service that is unparalleled in the reproductive health industry," said Elizabeth Hearty, Chief Executive Officer of LABS, Inc. "Ambry also brings to the table strong innovation and cutting-edge technologies within the genetic diagnostic market and that will effectively serve our clients."

Ambry is a specialized laboratory focused solely on genetic testing and diagnostic services. The Company operates in a highly consultative manner with hands-on customer service and individualized attention. LABS, Inc. has been serving the transplant community for nearly 30 years in the areas of infectious disease, immunogenetics and microbiology. LABS, Inc. brings unparalleled consultative and regulatory expertise to its customers.

"We are excited about partnering with LABS, Inc. to give more people access to this critical genetic test," said Steven Keiles, Vice President of Diagnostic Services of Ambry Genetics. "LABS, Inc.'s reputation for excellence in the reproductive health field made them a perfect partner to expand our offerings."

About LABS, Inc.

LABS, Inc. is the premier transplant medicine reference laboratory in the country that brings unparalleled consultative expertise and industry knowledge to its clients. Our FDA registered, CLIA-certified and CAP accredited testing is focused on four core competencies; infectious disease screening, microbiology, immunogenetics and cell/molecular biology, while serving clients in a variety of industries from transplant and transfusion to implantable biologics and tissue-based devices.. LABS, Inc. is committed to respectfully fulfilling the wishes of donors by ensuring the gift is able to generate positive patient outcomes. LABS, Inc. employs over 180 people. The company headquarters is located in Centennial, CO with satellite facilities in St. Louis, MO and Philadelphia, PA. To learn more, visit www.labs-inc.org.

About Ambry Genetics

Ambry Genetics is a CAP-accredited, CLIA-certified commercial clinical laboratory headquartered in Aliso Viejo, California. Since the company's inception in 2000, it has become a leader in providing genetic services focused on clinical diagnostics and genomic services. Ambry has built a solid reputation for unparalleled service, and has been at the forefront of applying new technologies to the clinical molecular diagnostics market and advancements in disease research. To learn more about testing and services available through Ambry, visit www.ambrygen.com.

SOURCE LABS, Inc.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES